ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,213.49
0.51%
Dow Jones
38,675.68
1.18%
Gold vs US Dollar
2,302.875
0.01%
Brent Oil
82.765
0.00%
Bitcoin
63,727.44
-0.26%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Poolbeg Pharma Plc (POLB)

  7. Poolbeg Pharma Plc (POLB) News

Poolbeg Pharma (POLB)

Poolbeg Pharma Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:POLB
DateTimeSourceHeadlineSymbolCompany
01/05/202416:39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202416:39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Significant POLB 001 Patent Granted in USALSE:POLBPoolbeg Pharma Plc
30/04/202416:30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202416:30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202407:02RNS Regulatory NewsPoolbeg Pharma PLC Appointment of Joint BrokerLSE:POLBPoolbeg Pharma Plc
30/04/202407:01RNS Regulatory NewsPoolbeg Pharma PLC Option Agreement to Acquire Orphan Drug CandidateLSE:POLBPoolbeg Pharma Plc
30/04/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Results for the year ended 31 December 2023LSE:POLBPoolbeg Pharma Plc
29/04/202407:00RNS Regulatory NewsPoolbeg Pharma PLC TR-1: Notification of major holdingsLSE:POLBPoolbeg Pharma Plc
20/03/202416:18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202416:18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202407:00RNS Regulatory NewsPoolbeg Pharma PLC POLB 001 US Patent UpdateLSE:POLBPoolbeg Pharma Plc
22/02/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Director/PDMR ShareholdingLSE:POLBPoolbeg Pharma Plc
19/02/202413:42RNS Regulatory NewsPoolbeg Pharma PLC Director Share PurchaseLSE:POLBPoolbeg Pharma Plc
15/02/202416:02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
15/02/202416:02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
15/02/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Board Role Change and Launch of EIPLSE:POLBPoolbeg Pharma Plc
12/02/202419:44Alliance NewsAlliance NewsTRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-upLSE:POLBPoolbeg Pharma Plc
12/02/202419:44Alliance NewsAlliance NewsTRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-upLSE:POLBPoolbeg Pharma Plc
12/02/202407:00RNS Regulatory NewsPoolbeg Pharma PLC Market Opportunity for POLB 001 for CRSLSE:POLBPoolbeg Pharma Plc
17/01/202413:58Alliance NewsAlliance NewsPoolbeg Pharma hails POLB 001'S potential to treat CRSLSE:POLBPoolbeg Pharma Plc
17/01/202413:58Alliance NewsAlliance NewsPoolbeg Pharma hails POLB 001'S potential to treat CRSLSE:POLBPoolbeg Pharma Plc
17/01/202407:00UK RegulatoryPoolbeg Pharma PLC Further data shows POLB001 potential in cancer CRSLSE:POLBPoolbeg Pharma Plc
20/12/202320:00Alliance NewsAlliance NewsTRADING UPDATES: K3 Business says cash balances ahead of forecastLSE:POLBPoolbeg Pharma Plc
20/12/202320:00Alliance NewsAlliance NewsTRADING UPDATES: K3 Business says cash balances ahead of forecastLSE:POLBPoolbeg Pharma Plc
20/12/202307:00UK RegulatoryPoolbeg Pharma PLC RSV AI Drug Candidate Analysis UpdateLSE:POLBPoolbeg Pharma Plc
11/12/202307:00UK RegulatoryPoolbeg Pharma PLC POLB 001 Data Presented at ASHLSE:POLBPoolbeg Pharma Plc
30/11/202307:00UK RegulatoryPoolbeg Pharma PLC Directorate ChangeLSE:POLBPoolbeg Pharma Plc
21/11/202314:39Alliance NewsAlliance NewsTRADING UPDATES: Poolbeg hails approval; EDX links with Thermo FisherLSE:POLBPoolbeg Pharma Plc
21/11/202314:39Alliance NewsAlliance NewsTRADING UPDATES: Poolbeg hails approval; EDX links with Thermo FisherLSE:POLBPoolbeg Pharma Plc
 Showing the most relevant articles for your search:LSE:POLB

Your Recent History

LSE
CHLL
Chill Brands
LSE
AGL
Angle
LSE
SRSP
Sirius Petroleum
LSE
SCE
Surface Transforms
LSE
POS
Plexus
LSE
INSG
Insig Ai
LSE
AAZ
Anglo Asian Mining
LSE
SCLP
Scancell
LSE
AAU
Ariana Resources
LSE
SBTX
Skinbiotherapeutics
LSE
BIRD
Blackbird
LSE
HUM
Hummingbird Resources
LSE
APTA
Aptamer
LSE
LLOY
Lloyds Banking
LSE
GFM
Griffin Mining
LSE
ALBA
Alba Mineral Resources
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved